|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0150 CAD | 0.00% |
|
0.00% | -75.00% |
| 04-02 | RAMM Pharma Corp. Reports Earnings Results for the First Quarter Ended January 31, 2026 | CI |
| 03-05 | RAMM Pharma Corp. Reports Earnings Results for the Full Year Ended October 31, 2025 | CI |
| Market Cap | 1.79M 1.26M 1.1M 1.02M 955K 119M 1.8M 12.1M 4.69M 58.67M 4.74M 4.64M 204M | P/E 2024 |
-0.07x | P/E 2025 | -0.2x |
|---|---|---|---|---|---|
| Enterprise Value | 1.07M 753K 656K 608K 569K 71.04M 1.07M 7.21M 2.8M 34.97M 2.83M 2.77M 121M | EV / Sales 2024 |
0.13x | EV / Sales 2025 | 0.32x |
| Free-Float |
68.57% | Yield 2024 * |
-
| Yield 2025 | - |
| 6 months | -62.50% | ||
| Current year | -75.00% |
| 1 month | 0.01 | 0.02 | |
| Current year | 0.01 | 0.05 | |
| 1 year | 0.01 | 0.25 | |
| 3 years | 0 | 0.25 | |
| 5 years | 0 | 1 | |
| 10 years | 0 | 1.19 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jackie Burnett
CEO | Chief Executive Officer | - | 30/09/2019 |
José Roldan
DFI | Director of Finance/CFO | - | 08/12/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Jackie Burnett
BRD | Director/Board Member | - | 30/09/2019 |
Daniel Augereau
BRD | Director/Board Member | 82 | 30/09/2019 |
Eric Klein
BRD | Director/Board Member | 66 | 30/09/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 01/06/25 | Sell | Chief Executive Officer | 4,667,000 | 3.9091% | ||
| 20/03/25 | Buy | Chief Executive Officer | 200,000 | 0.1675% | ||
| 20/03/25 | Buy | Chief Executive Officer | 100,000 | 0.0838% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | 0.00% | +50.00% | -70.00% | 1.26M | ||
| +0.13% | -2.75% | +42.51% | +139.96% | 980B | ||
| +0.70% | -2.69% | +51.55% | +38.46% | 550B | ||
| +4.92% | +2.24% | +23.29% | +64.88% | 382B | ||
| -0.13% | -3.09% | +23.33% | +16.78% | 316B | ||
| +0.36% | +0.26% | +27.01% | +14.09% | 272B | ||
| +1.28% | -0.83% | +25.39% | +32.38% | 268B | ||
| +0.97% | +3.50% | -34.41% | -45.56% | 199B | ||
| +1.46% | -2.24% | +25.78% | +49.21% | 182B | ||
| +0.44% | -0.32% | +16.68% | +58.62% | 154B | ||
| Average | +0.95% | -2.43% | +25.11% | +29.88% | 330.23B | |
| Weighted average by Cap. | +0.94% | -3.50% | +30.53% | +63.52% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 4.34M 3.06M 2.67M 2.47M 2.32M 289M 4.37M 29.34M 11.37M 142M 11.5M 11.25M 494M | 3.36M 2.37M 2.07M 1.91M 1.79M 224M 3.38M 22.71M 8.8M 110M 8.9M 8.71M 382M |
| Net income | -16.5M -11.64M -10.15M -9.4M -8.8M -1.1B -16.6M -112M -43.22M -541M -43.69M -42.76M -1.88B | -8.91M -6.28M -5.48M -5.08M -4.75M -593M -8.96M -60.21M -23.33M -292M -23.59M -23.09M -1.01B |
| Net Debt | -626K -441K -385K -356K -334K -41.65M -630K -4.23M -1.64M -20.5M -1.66M -1.62M -71.18M | -723K -510K -445K -412K -386K -48.15M -728K -4.89M -1.89M -23.7M -1.92M -1.87M -82.3M |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- RAMM Stock
Select your edition
All financial news and data tailored to specific country editions
















